Search for: "Pfizer Inc."
Results 221 - 240
of 1,378
Sorted by Relevance
|
Sort by Date
1 Oct 2010, 9:00 am
Pfizer Consumer Healthcare Issues Voluntary Recall of One Lot of ThermaCare HeatWraps Menstrual Product Pfizer Consumer Healthcare, a business of Pfizer, Inc., has announced a voluntary recall of one lot of its ThermaCare HeatWraps Menstrual product distributed in the United States and Puerto Rico.The company said it is taking this precautionary step after finding a potential for a leak of the components contained in the wrap, which could cause skin injury such… [read post]
1 Feb 2007, 2:04 pm
Harper As we previously reported, last year a jury in the Eastern District of Virginia found that Pfizer does not infringe Synthon IP, Inc.'s patent on processes for making the active ingredient in Norvasc (amlodipine besylate) and also that the patent is invalid. [read post]
17 May 2013, 9:09 am
In Pfizer Inc. et al. v. [read post]
13 Jul 2010, 5:00 am
Pfizer, Inc. [read post]
15 Apr 2010, 5:09 am
— South Carolina is to receive $11 million under an agreement with Pfizer Inc. over the company's disputed sales tactics for certain drugs, double the amount the state said Friday it would have gotten under a multistate deal struck last year.Under the deal finalized Thursday and confirmed by Pfizer, the New York-based pharmaceutical giant also is to give South Carolina more than $1.5 million in medications for use in its free clinics.In September, federal… [read post]
15 Nov 2007, 1:49 pm
Pfizer, Inc., No. 06-2627. [read post]
2 Jan 2011, 9:18 pm
Pfizer, Inc. 2:10-cv-00599; filed December 29, 2010 in the Eastern District of Texas False marking based on Pfizer's marking of thirteen different products from its Animal Health Division with various patents (twenty in total) that have expired. [read post]
14 Oct 2009, 6:26 am
Pfizer's Acquisition of Wyeth Clears Antitrust HurdlesThis posting was written by Jeffrey May, Editor of CCH Trade Regulation Reporter.Pfizer, Inc.'s proposed $68 billion acquisition of Wyeth was conditionally approved by the Federal Trade Commission (FTC) today. [read post]
7 Sep 2004, 11:28 pm
The Deal reports on Pfizer Inc.'s $965 billion settlement clearing all current and future asbestos litigation against the company.... [read post]
8 Apr 2013, 9:26 pm
Court of Appeals in Boston affirmed verdicts of over $140 million, reached by both a jury and trial court, in favor of Kaiser Foundation Health Plan, Inc. for injuries suffered as a result of Pfizer, Inc. [read post]
28 Mar 2012, 6:45 am
The tablets were manufactured and packaged by Pfizer Inc., commercialized by Akrimax Rx Products and labeled under the Akrimax Pharmaceuticals brand. [read post]
12 Oct 2011, 8:38 am
The following item appeared on October 11, 2011 at Device Space: Pfizer Inc. announced today that the company has settled its patent-infringement case against Teva and several other parties in respect of Teva's generic form of Lipitor in the U.K. [read post]
In Pfizer off-label qui tam, Massachusetts District Court rejects broad implied certification theory
19 Sep 2010, 10:20 pm
Pfizer Inc, Judge Patty Saris of the District of Massachusetts granted summary judgment to the company in the long-fought case. [read post]
6 Mar 2024, 10:15 am
Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Pfizer Inc. v. [read post]
6 Mar 2024, 10:15 am
Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Pfizer Inc. v. [read post]
22 Mar 2007, 9:03 am
Pfizer, Inc. v. [read post]
31 Jan 2012, 6:31 pm
Pfizer Inc., the world’s biggest drugmaker, recalled 1 million packs of birth-control pills after discovering a packaging error that may cause women to take the wrong dosages and put them at risk for unintended pregnancies.The company recalled 14 lots of Lo/Ovral-28 tablets and 14 lots of a generic version of the medicine, New York-based Pfizer said today in an e-mail. [read post]
30 May 2008, 1:39 pm
Yesterday, Pfizer fell 3 cents to $19.30 in New York Stock Exchange composite trading. [read post]
11 Mar 2010, 9:59 pm
District Court for the District of Columbia remanded Pfizer Inc.'s challenge of the USPTO's calculation of patent term adjustment (PTA) back to the U.S. [read post]
28 Jan 2009, 3:15 am
According to an article by The Legal Intelligencer, Pfizer Inc. has made no secret of its intentions to slash thousands of jobs once a planned merger with pharmaceutical competitor Wyeth goes through.How Wyeth's 300-person worldwide legal department will be affected is still a question mark. [read post]
